{"id":3850,"date":"2017-08-12T18:58:11","date_gmt":"2017-08-12T18:58:11","guid":{"rendered":"https:\/\/andromedichyperthermia.com\/deep-local-hyperthermia-meht\/"},"modified":"2026-02-11T12:38:20","modified_gmt":"2026-02-11T12:38:20","slug":"moduliuota-rf-hipertermija","status":"publish","type":"page","link":"https:\/\/andromedichyperthermia.com\/lt\/moduliuota-rf-hipertermija\/","title":{"rendered":"Moduliuota RF-Hipertermija ( 13,56 MHz RF mHT + RF b\u016bdinga patologijai )"},"content":{"rendered":"<p><script type=\"application\/ld+json\">\n{\n  \"@context\": \"https:\/\/schema.org\",\n  \"@graph\": [\n    {\n      \"@type\": \"Article\",\n      \"@id\": \"https:\/\/andromedichyperthermia.com\/lt\/moduliuota-rf-hipertermija\/#article\",\n      \"mainEntityOfPage\": {\n        \"@type\": \"WebPage\",\n        \"@id\": \"https:\/\/andromedichyperthermia.com\/lt\/moduliuota-rf-hipertermija\/\"\n      },\n      \"headline\": \"Moduliuota RF hipertermija \u2013 13,56 MHz mHT\",\n      \"description\": \"Moduliuota RF hipertermija (mHT) yra pa\u017eangi \u0161ildymo terapija, kuri selektyviai veikia ir naikina piktybines l\u0105steles, nepa\u017eeisdama sveik\u0173 audini\u0173. \u0160i naujausios kartos medicinin\u0117 inovacija u\u017etikrina tiksli\u0105, kontroliuojam\u0105 ir gili\u0105 energij\u0105, naudodama 13,56 MHz moduliuot\u0105 radijo da\u017en\u012f.\",\n      \"image\": {\n        \"@type\": \"ImageObject\",\n        \"url\": \"https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/07\/modulated-RF-HT-selective-cancer-cells-300x213.jpg\",\n        \"width\": 300,\n        \"height\": 213,\n        \"caption\": \"Moduliuota RF hipertermija \u2013 selektyvus v\u0117\u017eini\u0173 l\u0105steli\u0173 naikinimas\"\n      },\n      \"datePublished\": \"2025-07-28T00:00:00+02:00\",\n      \"dateModified\": \"2026-02-11T14:45:00+02:00\",\n      \"author\": { \"@id\": \"https:\/\/andromedichyperthermia.com\/#organization\" },\n      \"publisher\": { \"@id\": \"https:\/\/andromedichyperthermia.com\/#organization\" },\n      \"keywords\": [\n        \"Moduliuota RF hipertermija\", \"mHT\", \"13.56 MHz\", \"selektyvus v\u0117\u017eio gydymas\",\n        \"hiperterminis poveikis\", \"elektromagnetinis poveikis\", \"v\u0117\u017eio terapija\",\n        \"chemoterapijos stiprinimas\", \"radioterapijos stiprinimas\", \"imunoterapijos stiprinimas\",\n        \"abskopalinis efektas\", \"bendras i\u0161gyvenamumas\", \"gyvenimo kokyb\u0117\", \"adjuvantin\u0117 terapija\",\n        \"neoadjuvantin\u0117 terapija\", \"paliatyvioji terapija\", \"infekcijos\", \"u\u017edegimas\", \"skausmas\",\n        \"Andromedic HyDeep 600WM\", \"RF moduliacija\", \"naviko mikroaplinka\", \"DAMP\", \"ICD\",\n        \"imunogenin\u0117 l\u0105steli\u0173 \u017e\u016btis\", \"HSPs\", \"NK l\u0105stel\u0117s\", \"DC l\u0105stel\u0117s\", \"CTL\", \"Th1\", \"T-atminties l\u0105stel\u0117s\",\n        \"nivolumabas\", \"ipilimumabas\", \"interleukinas 2\"\n      ],\n      \"about\": [\n        {\n          \"@type\": \"MedicalTherapy\",\n          \"name\": \"Moduliuota RF hipertermija\",\n          \"alternateName\": [\"mHT\", \"RF hipertermija\", \"hipertermijos terapija\"]\n        },\n        {\n          \"@type\": \"MedicalCondition\",\n          \"name\": \"V\u0117\u017eys\",\n          \"alternateName\": [\"Piktybin\u0117s l\u0105stel\u0117s\", \"Navikai\", \"Onkologin\u0117s patologijos\", \"Neoplastin\u0117s patologijos\"]\n        },\n        {\n          \"@type\": \"MedicalDevice\",\n          \"@id\": \"https:\/\/andromedichyperthermia.com\/lt\/onkologines-hipertermijos-prietaisas\/#device\",\n          \"name\": \"Andromedic HyDeep 600WM mHT prietaisas\",\n          \"description\": \"\u201eHyDeep 600 WM\u201c yra pa\u017eangi onkologin\u0117s hipertermijos sistema\/prietaisas, giliosios vietin\u0117s hipertermijos sistema\/prietaisas, moduliuotos RF hipertermijos sistema\/prietaisas bei elektrohipertermijos sistema\/prietaisas.\",\n          \"manufacturer\": { \"@id\": \"https:\/\/andromedichyperthermia.com\/#organization\" },\n          \"url\": \"https:\/\/andromedichyperthermia.com\/lt\/onkologines-hipertermijos-prietaisas\/\"\n        },\n        {\n          \"@type\": \"MedicalTherapy\",\n          \"name\": \"Chemoterapija\",\n          \"url\": \"https:\/\/www.kosinmedj.org\/journal\/view.php?number=1294\"\n        },\n        {\n          \"@type\": \"MedicalTherapy\",\n          \"name\": \"Radioterapija\",\n          \"url\": \"https:\/\/www.kosinmedj.org\/journal\/view.php?number=1294\"\n        },\n        {\n          \"@type\": \"MedicalTherapy\",\n          \"name\": \"Imunoterapija\",\n          \"url\": \"https:\/\/www.mdpi.com\/2072-6694\/15\/18\/4569\"\n        }\n      ],\n      \"mentions\": [\n        { \"@type\": \"Thing\", \"name\": \"13.56 MHz\", \"description\": \"Radijo da\u017enio ne\u0161lio da\u017enis\" },\n        { \"@type\": \"Thing\", \"name\": \"RF moduliacija\" },\n        { \"@type\": \"Thing\", \"name\": \"Elektromagnetinis poveikis\" },\n        { \"@type\": \"Thing\", \"name\": \"Terminis poveikis\" },\n        { \"@type\": \"Thing\", \"name\": \"Talpinis ry\u0161ys\" },\n        { \"@type\": \"Thing\", \"name\": \"Var\u017ea\", \"alternateName\": \"Impedansas\" },\n        { \"@type\": \"Thing\", \"name\": \"U\u017el\u0105stelinis elektrolitas\" },\n        { \"@type\": \"Thing\", \"name\": \"DNR reparacijos mechanizmas\" },\n        { \"@type\": \"Thing\", \"name\": \"Perfuzija\" },\n        { \"@type\": \"Thing\", \"name\": \"Oksigenacija\" },\n        { \"@type\": \"Thing\", \"name\": \"Vazodiliatacijos efektas\" },\n        { \"@type\": \"Thing\", \"name\": \"Radiosensibilizacija\" },\n        { \"@type\": \"Thing\", \"name\": \"Naviko mikroaplinka\", \"alternateName\": \"TME\" },\n        { \"@type\": \"Thing\", \"name\": \"DAMP\", \"description\": \"Su pavojaus signalais susij\u0119 molekuliniai modeliai\" },\n        { \"@type\": \"Thing\", \"name\": \"Imunogenin\u0117 l\u0105steli\u0173 \u017e\u016btis\", \"alternateName\": \"ICD\" },\n        { \"@type\": \"Thing\", \"name\": \"\u0160iluminio \u0161oko baltymai\", \"alternateName\": \"HSPs\" },\n        { \"@type\": \"Thing\", \"name\": \"Nat\u016bralios \u017eudik\u0117s\", \"alternateName\": \"NK l\u0105stel\u0117s\" },\n        { \"@type\": \"Thing\", \"name\": \"Dendritin\u0117s l\u0105stel\u0117s\", \"alternateName\": \"DC l\u0105stel\u0117s\" },\n        { \"@type\": \"Thing\", \"name\": \"Citotoksiniai T limfocitai\", \"alternateName\": \"CTL\" },\n        { \"@type\": \"Thing\", \"name\": \"T-pagalbin\u0117s l\u0105stel\u0117s\", \"alternateName\": \"Th1\" },\n        { \"@type\": \"Thing\", \"name\": \"T-atminties l\u0105stel\u0117s\", \"alternateName\": \"Tmemory\" },\n        { \"@type\": \"Thing\", \"name\": \"Abskopalinis efektas\" },\n        { \"@type\": \"Thing\", \"name\": \"Bendras i\u0161gyvenamumas\", \"alternateName\": \"OS\" },\n        { \"@type\": \"Thing\", \"name\": \"Gyvenimo kokyb\u0117\", \"alternateName\": \"QoL\" },\n        { \"@type\": \"Thing\", \"name\": \"Adjuvantin\u0117 terapija\" },\n        { \"@type\": \"Thing\", \"name\": \"Neoadjuvantin\u0117 terapija\" },\n        { \"@type\": \"Thing\", \"name\": \"Paliatyvioji terapija\" },\n        { \"@type\": \"Person\", \"name\": \"Hegyi G\" },\n        { \"@type\": \"Person\", \"name\": \"Szasz O\" },\n        { \"@type\": \"Person\", \"name\": \"Szasz A\" },\n        { \"@type\": \"Person\", \"name\": \"Ralph Kleef\" },\n        { \"@type\": \"Thing\", \"name\": \"Nivolumabas\" },\n        { \"@type\": \"Thing\", \"name\": \"Ipilimumabas\" },\n        { \"@type\": \"Thing\", \"name\": \"Interleukinas 2\" }\n      ],\n      \"citation\": [\n        \"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC5356646\/\",\n        \"https:\/\/www.kosinmedj.org\/journal\/view.php?number=1294#f1-kmj-24-127\",\n        \"https:\/\/www.mdpi.com\/2072-6694\/15\/18\/4569\",\n        \"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC9939221\/\",\n        \"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC10663566\/\"\n      ]\n    },\n    {\n      \"@type\": \"MedicalOrganization\",\n      \"@id\": \"https:\/\/andromedichyperthermia.com\/#organization\",\n      \"name\": \"Andromedic Hyperthermia\",\n      \"url\": \"https:\/\/andromedichyperthermia.com\/lt\/\",\n      \"logo\": {\n        \"@type\": \"ImageObject\",\n        \"url\": \"https:\/\/andromedichyperthermia.com\/logo.png\"\n      }\n    }\n  ]\n}\n<\/script><\/p>\n<div class=\"mht-clinical-container\" style=\"max-width: 1100px; margin: 0 auto; font-family: 'Segoe UI', Roboto, Helvetica, Arial, sans-serif; color: #2c3e50; line-height: 1.7;\">\n<header style=\"border-bottom: 3px solid #004a99; margin-bottom: 30px; padding-bottom: 20px;\">\n<h1 style=\"color: #004a99; font-size: 2.4em; margin-bottom: 10px;\">Moduliuota RF hipertermija \u2013 13,56 MHz mHT technologija<\/h1>\n<p style=\"font-size: 1.15em; font-weight: 400;\">Moduliuota RF hipertermija (mHT) yra pa\u017eangus \u0161iluminis gydymas, naudojantis <strong>sinergetin\u012f termin\u012f ir netermin\u012f (elektromagnetin\u012f) poveik\u012f<\/strong>, siekiant <strong>SELEKTYVIAI<\/strong> kaitinti ir naikinti piktybines l\u0105steles, nepa\u017eeid\u017eiant sveik\u0173j\u0173 audini\u0173.<\/p>\n<\/header>\n<div style=\"display: flex; flex-wrap: wrap; gap: 40px; margin-bottom: 50px; align-items: flex-start;\">\n<div style=\"flex: 1; min-width: 320px;\">\n<p>mHT yra naujausios kartos medicinin\u0117 inovacija, kuri v\u0117\u017eio l\u0105stel\u0117ms teikia <strong>selektyvi\u0105, kontroliuojam\u0105 ir gili\u0105 energij\u0105 (hipertermin\u0119 + elektromagnetin\u0119)<\/strong>, naudojant talpiniu b\u016bdu susiet\u0105 13,56 MHz amplitud\u0117s moduliuot\u0105 radijo da\u017en\u012f.<\/p>\n<div style=\"background: #f0f7ff; border-left: 5px solid #004a99; padding: 20px; margin: 20px 0;\">\n<h2 style=\"margin-top: 0; color: #004a99; font-size: 1.3em;\">Prana\u0161us gilus poveikis onkologijoje<\/h2>\n<p>13,56 MHz mHT su dviem elektrodais gali prasiskverbti iki <strong>38,4 cm gyl\u012f<\/strong> ir \u012frod\u0117 savo prana\u0161um\u0105 prie\u0161 8 MHz cCHT<br \/>\n<a style=\"color: #004a99; text-decoration: underline;\" title=\"Comparative study on 13.56 MHz vs 8 MHz hyperthermia\" href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC5356646\/\" target=\"_blank\" rel=\"noopener\">(\u0160altinis)<\/a>.<\/p>\n<\/div>\n<p>mHT tiekia \u0161ilumin\u0119 energij\u0105 tik \u012f naviko l\u0105steli\u0173 membran\u0105 ir ekstral\u0105stelin\u0119 matric\u0105, naudojant \u017eemesn\u0119 nei 43 \u00b0C temperat\u016br\u0105, taip sprend\u017eiant tradicin\u0117s hipertermijos ribotumus <strong>beveik l\u0105steli\u0173 lygmeniu<\/strong>.<\/p>\n<\/div>\n<div style=\"flex: 1; min-width: 320px; text-align: center;\">\n<figure style=\"margin: 0; background: #fff; padding: 15px; border: 1px solid #e1e8ed; border-radius: 8px; box-shadow: 0 4px 12px rgba(0,0,0,0.08);\"><img decoding=\"async\" style=\"width: 100%; height: auto; border-radius: 4px;\" title=\"Selektyvus mHT mechanizmas\" src=\"https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/07\/modulated-RF-HT-selective-cancer-cells-300x213.jpg\" alt=\"Selektyvus moduliuotos RF hipertermijos mHT mechanizmas navikin\u0117ms l\u0105stel\u0117ms - HyDeep 600WM\" \/><figcaption style=\"font-size: 0.9em; text-align: left; padding-top: 15px; line-height: 1.4; color: #576574;\"><strong>1 pav. Selektyvus mHT mechanizmas.<\/strong> Moduliuota radijo da\u017enio srov\u0117 teka daugiausia \u012f ekstral\u0105stelin\u012f elektrolit\u0105, nes normalios l\u0105stel\u0117s yra elektroniniu b\u016bdu izoliuotos daugiau nei vieno milijono V\/m elektrinio lauko stiprumu <em>(Hegyi G, Szasz O, Szasz A. PMID: 24494322.)<\/em><\/figcaption><\/figure>\n<\/div>\n<\/div>\n<h2 style=\"color: #004a99; text-align: center; margin-bottom: 35px;\">Amplitud\u0117s moduliuotos RF hipertermijos klinikin\u0117 nauda<\/h2>\n<div style=\"display: grid; grid-template-columns: repeat(auto-fit, minmax(320px, 1fr)); gap: 25px; margin-bottom: 50px;\">\n<div style=\"background: #fff; border: 1px solid #e1e8ed; border-top: 4px solid #004a99; padding: 25px; border-radius: 0 0 8px 8px;\">\n<h3 style=\"margin-top: 0; color: #004a99; font-size: 1.2em;\">Chemoterapija ir biologinis palaikymas<\/h3>\n<p style=\"font-size: 0.95em;\"><strong>Geresn\u0117 perfuzija:<\/strong> D\u0117l vazodiliatacijos efekto, mHT u\u017etikrina geresn\u012f chemoterapini\u0173 ar biologini\u0173 med\u017eiag\u0173 patekim\u0105 <a title=\"Kosin Medical Journal: Hyperthermia outcomes\" href=\"https:\/\/www.kosinmedj.org\/journal\/view.php?number=1294\" target=\"_blank\" rel=\"noopener\">(\u0161altinis)<\/a>, taip gerinant gydymo rezultatus.<\/p>\n<\/div>\n<div style=\"background: #fff; border: 1px solid #e1e8ed; border-top: 4px solid #004a99; padding: 25px; border-radius: 0 0 8px 8px;\">\n<h3 style=\"margin-top: 0; color: #004a99; font-size: 1.2em;\">Radiosensibilizacija<\/h3>\n<p style=\"font-size: 0.95em;\">Naviko ir aplinkini\u0173 audini\u0173 <strong>oksigenacijos<\/strong> poky\u010diai daro mHT puikiu pasirinkimu prie\u0161 ir po radioterapijos, jautrinant navik\u0105 ir padidinant radiacijos efektyvum\u0105 <a title=\"Study on radiosensitization and mHT\" href=\"https:\/\/www.kosinmedj.org\/journal\/view.php?number=1294\" target=\"_blank\" rel=\"noopener\">(\u0161altinis)<\/a>.<\/p>\n<\/div>\n<div style=\"background: #fdf2f2; border: 1px solid #f8d7da; border-top: 4px solid #d9534f; padding: 25px; border-radius: 0 0 8px 8px;\">\n<h3 style=\"margin-top: 0; color: #c0392b; font-size: 1.2em;\">Imunogeninis poveikis (Abscopal)<\/h3>\n<p style=\"font-size: 0.9em; line-height: 1.5;\"><strong>ICD suk\u0117l\u0117jas:<\/strong> mHT moduliuoja naviko mikroaplink\u0105 (TME), aktyvuodama <strong>DAMP<\/strong> ir <strong>HSP70<\/strong>. Tai stimuliuoja NK l\u0105steles ir brandina dendritines l\u0105steles (DC), sukurdama sistemin\u012f atsak\u0105 \u012f tolim\u0105sias metastazes.<\/p>\n<div style=\"font-family: monospace; font-size: 0.85em; background: #fff; padding: 10px; border-radius: 4px; border: 1px dashed #d9534f; margin-top: 10px;\">mHT (ICD suk\u0117l\u0117jas) -&gt; DAMP -&gt; HSP70 -&gt; DC -&gt; T-l\u0105stel\u0117s (CTL, Th1, T-atminties) -&gt; <strong>Sistemin\u0117 prie\u0161navikin\u0117 reakcija<\/strong><\/div>\n<p style=\"font-size: 0.85em; margin-top: 10px; color: #7f8c8d;\">Ralph Kleef et al. tyrimas parod\u0117 prana\u0161um\u0105 prie\u0161 nivolumab\u0105 ir ipilimumab\u0105 gydant vir\u0161kinamojo trakto v\u0117\u017e\u012f<br \/>\n<a title=\"Study by Ralph Kleef on mHT and Immunotherapy\" href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC10663566\/\" target=\"_blank\" rel=\"noopener\">(\u0161altinis)<\/a>.<\/p>\n<\/div>\n<\/div>\n<div style=\"background: #f8fbff; padding: 30px; border-radius: 12px; border: 1px solid #e1e8ed; margin-bottom: 50px;\">\n<h3 style=\"color: #004a99; margin-top: 0;\">Klinikiniai rezultatai: Bendras i\u0161gyvenamumas (OS) ir QoL<\/h3>\n<p>Klinikiniais tyrimais ne kart\u0105 \u012frodyta, kad papildomai taikant mHT <strong>padid\u0117ja bendras i\u0161gyvenamumas (OS)<\/strong>, u\u017etikrinama vietin\u0117 naviko kontrol\u0117 ir pager\u0117ja <strong>gyvenimo kokyb\u0117 (QoL)<\/strong> <a title=\"Clinical evidence on OS and QoL with mHT\" href=\"https:\/\/www.mdpi.com\/2072-6694\/15\/18\/4569\" target=\"_blank\" rel=\"noopener\">(\u0161altinis)<\/a>.<\/p>\n<p style=\"font-style: italic; font-size: 0.95em; color: #576574;\">Palaikomasis adjuvantinis, neoadjuvantinis ir paliatyvus gydymas esant neoplastin\u0117ms patologijoms, infekcijoms, u\u017edegimams bei skausmui.<\/p>\n<\/div>\n<section style=\"background: linear-gradient(135deg, #004a99 0%, #002d5d 100%); color: #fff; padding: 40px; border-radius: 15px; text-align: center; box-shadow: 0 10px 20px rgba(0,74,153,0.2);\">\n<h2 style=\"color: #fff; margin-top: 0; font-size: 1.8em;\">Pa\u017eangi mHT: Andromedic HyDeep 600WM<\/h2>\n<p style=\"font-size: 1.1em; max-width: 800px; margin: 0 auto 25px auto;\">Andromedic moduliuotos hipertermijos prietaisas naudoja 13,56 MHz ne\u0161ant\u012fj\u012f da\u017en\u012f ir derina j\u012f su <strong>kiekvienai patologijai bei v\u0117\u017eio tipui specifiniais radijo da\u017eniais<\/strong>, taip reik\u0161mingai pagerindamas klasikin\u0117s mHT rezultatus.<\/p>\n<p><a style=\"display: inline-block; background: #ffd700; color: #002d5d; padding: 15px 35px; border-radius: 30px; text-decoration: none; font-weight: bold; font-size: 1.1em; transition: transform 0.2s;\" href=\"https:\/\/andromedichyperthermia.com\/lt\/onkologines-hipertermijos-prietaisas\/\"><br \/>\nSusipa\u017einkite su HyDeep 600WM prietaiso technologija<br \/>\n<\/a><\/p>\n<\/section>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Moduliuota RF hipertermija (mHT) yra \u0161ilumin\u0117 terapija, naudojanti sinergetin\u012f termin\u012f ir netermin\u012f (elektromagnetin\u012f) poveik\u012f, siekiant SELEKTYVIAI kaitinti ir naikinti piktybines l\u0105steles, nepa\u017eeid\u017eiant sveik\u0173j\u0173 l\u0105steli\u0173. mHT yra naujausios kartos medicinin\u0117 inovacija, teikianti selektyvi\u0105, kontroliuojam\u0105 ir gili\u0105 energij\u0105 (hipertermin\u0119 + elektromagnetin\u0119) v\u0117\u017eio l\u0105stel\u0117ms, naudojant talpiniu b\u016bdu susiet\u0105 13,56 MHz amplitud\u0117s moduliuot\u0105 radijo da\u017en\u012f.<\/p>\n<p>13,56 MHz mHT su dviem elektrodais gali prasiskverbti iki 38,4 cm gyl\u012f ir \u012frod\u0117 savo prana\u0161um\u0105 prie\u0161 8 MHz cCHT.<\/p>\n<p>Be to, Andromedic HyDeep 600WM (pa\u017eangus onkologin\u0117s hipertermijos prietaisas) naudoja 13,56 MHz kaip ne\u0161ant\u012fj\u012f RF da\u017en\u012f ir derina j\u012f su radijo da\u017eniais, specifiniais kiekvienai patologijai ir v\u0117\u017eio tipui, taip potencialiai pagerindamas klasikin\u0117s 13,56 MHz mHT rezultatus.<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-3850","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/andromedichyperthermia.com\/lt\/wp-json\/wp\/v2\/pages\/3850","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/andromedichyperthermia.com\/lt\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/andromedichyperthermia.com\/lt\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/andromedichyperthermia.com\/lt\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/andromedichyperthermia.com\/lt\/wp-json\/wp\/v2\/comments?post=3850"}],"version-history":[{"count":0,"href":"https:\/\/andromedichyperthermia.com\/lt\/wp-json\/wp\/v2\/pages\/3850\/revisions"}],"wp:attachment":[{"href":"https:\/\/andromedichyperthermia.com\/lt\/wp-json\/wp\/v2\/media?parent=3850"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}